POZ Community Forums

Meds, Mind, Body & Benefits => Research News & Studies => Topic started by: Hoyland on August 21, 2013, 12:13:29 am

Title: CoH and Sangamo to try again
Post by: Hoyland on August 21, 2013, 12:13:29 am
The City of Hope is applying to start a new Pl trial of the Sangamo Zinc Finger Nuclease HIV treatment. Here is the agenda item for next month's RAC meeting.

Quote
Discussion on Human Gene Transfer Protocol #1307-1240 titled: A
Phase I, Open-Label Study to Assess the Safety, Feasibility and
Engraftment of Zinc Finger Nucleases CCR5 Modified Autologous CD34+
Hematopoietic Stem/Progenitor Cells (Sb-728mr-Hspc) with Escalating
Doses Of Busulfan in HIV-1 (R5) Infected Subjects with Suboptimal CD4
Levels on Antiretroviral Therapy

PIs: Amrita Krishnan, M.D., City of Hope, Duarte, CA
John Zaia, M.D, City of Hope, Duarte, CA

If RAC recommend the trial goes ahead, then I think CoH will have to submit a new IND to the FDA before the trail can commence. It is possible that the trail could begin by the end of the year, if the FDA has no objections.

http://oba.od.nih.gov/oba/RAC/meetings/Sept2013/Sept_11-12_2013_agenda-Public_Draft.pdf (http://oba.od.nih.gov/oba/RAC/meetings/Sept2013/Sept_11-12_2013_agenda-Public_Draft.pdf)
Title: Re: CoH and Sangamo to try again
Post by: geobee on August 21, 2013, 09:53:15 am
This is different.  It's stem cells.  Previous trials modified T-Cells.
Title: Re: CoH and Sangamo to try again
Post by: freewillie99 on August 21, 2013, 11:49:49 am
This is different.  It's stem cells.  Previous trials modified T-Cells.

Large.